Bengaluru's Kempegowda International Airport to get live passenger tracker

The Xovis's 3D sensors will help detect passenger flow at departure gates, check-in, immigration, security hold areas of both domestic and international flights as well as visa sections

Moneycontrol News

September 05, 2020 / 16:05 IST

A tech-enabled queue management system has been rolled out at the Kempegowda International Airport. This will help reduce the amount of time spent waiting, enhance operational efficacy, and lead to better management of passenger flow during peak hours.

Apart from this, the Xovis PTS, which is a state-of-the-art passenger flow management system, will also display live waiting time on the screens at processing points, leading to lowered levels of stress for passengers, Deccan Herald reported.

The Xovis's 3D sensors will help detect passenger flow coordinates at departure gates, check-in, immigration, security hold areas of both domestic and international flights as well as visa sections.

The ceiling-mounted 3D sensors captures co-ordinates and computes passenger flow information. The accompanying software visualises the data on a real-time dashboard, the report said.

Xovis, a Swiss company manufactures and distributes 3D sensors and software solutions for people flow measurement. It currently employs 100 people located in Switzerland, the US, and China.

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show